A significant new study has found that women taking GLP-1 medications—drugs increasingly used for weight management and diabetes—show about 30% lower rates of breast cancer development. The retrospective analysis examined data from over 110,000 women, making it one of the largest cohort studies to explore this connection.

While researchers emphasize that more investigation is needed to understand the biological mechanisms at work, the findings suggest these widely-used medications may offer unexpected health benefits beyond their primary uses. This discovery could reshape how doctors and patients think about treatment options and preventative health strategies. Read the full story →

Today's takeaway: Sometimes the most important medical breakthroughs come from paying close attention to the unexpected patterns hiding in plain sight.